| 1,3-dinitrobenzene | decreases expression | ISO | RGD:69273 | 6480464 | 3-dinitrobenzene results in decreased expression of SOCS2 mRNA | CTD | PMID:22841810 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SOCS2 mRNA | CTD | PMID:17272397 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of SOCS2 mRNA | CTD | PMID:16751804 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1332166 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SOCS2 mRNA | CTD | PMID:18343893 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA | CTD | PMID:19692669 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SOCS2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1332166 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SOCS2 mRNA | CTD | PMID:19770486 PMID:18372398 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA | CTD | PMID:19692669 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1332166 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SOCS2 mRNA | CTD | PMID:18372398 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA | CTD | PMID:20106945 PMID:19692669 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1332166 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SOCS2 mRNA | CTD | PMID:18372398 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1332166 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA; more ... | CTD | PMID:15371557 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1332166 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SOCS2 mRNA | CTD | PMID:18343893 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1332166 | 6480464 | AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SOCS2 protein]; more ... | CTD | PMID:15371557 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:1332166 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SOCS2 mRNA | CTD | PMID:15371557 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SOCS2 mRNA | CTD | PMID:19692669 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:69273 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of SOCS2 mRNA | CTD | PMID:19162173 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of SOCS2 mRNA | CTD | PMID:15982314 |
| acetylsalicylic acid | increases expression | ISO | RGD:1332166 | 6480464 | Aspirin results in increased expression of SOCS2 mRNA | CTD | PMID:16415877 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:1332166 | 6480464 | butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine inhibits the reaction [Aspirin results in increased expression of SOCS2 mRNA]; more ... | CTD | PMID:16415877 |
| afimoxifene | increases expression | EXP | | 6480464 | 4-hydroxytamoxifen results in increased expression of SOCS2 mRNA | CTD | PMID:23373633 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of SOCS2 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin metabolite results in increased expression of SOCS2 mRNA; more ... | CTD | PMID:15982314 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SOCS2 mRNA | CTD | PMID:15982314 PMID:21934132 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SOCS2 mRNA | CTD | PMID:21934132 PMID:15982314 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1332166 | 6480464 | Tretinoin results in decreased expression of SOCS2 mRNA | CTD | PMID:16788091 |
| ammonium chloride | affects expression | ISO | RGD:69273 | 6480464 | Ammonium Chloride affects the expression of SOCS2 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SOCS2 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SOCS2 mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:1332166 | 6480464 | Benzo(a)pyrene results in increased expression of SOCS2 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1332166 | 6480464 | Benzo(a)pyrene results in decreased expression of SOCS2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1332166 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SOCS2 mRNA | CTD | PMID:21715664 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1332166 | 6480464 | Diethylhexyl Phthalate results in decreased expression of SOCS2 mRNA | CTD | PMID:21318169 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SOCS2 mRNA | CTD | PMID:16029874 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of SOCS2 mRNA | CTD | PMID:16002434 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SOCS2 mRNA | CTD | PMID:21592394 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of SOCS2 mRNA | CTD | PMID:21592394 |
| choline | multiple interactions | ISO | RGD:1332166 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SOCS2 mRNA; more ... | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1332166 | 6480464 | Ciguatoxins affects the expression of SOCS2 mRNA | CTD | PMID:18353800 |
| cisplatin | affects response to substance | EXP | | 6480464 | SOCS2 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| cisplatin | decreases expression | ISO | RGD:69273 | 6480464 | Cisplatin results in decreased expression of SOCS2 mRNA | CTD | PMID:22023808 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SOCS2 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SOCS2 mRNA; more ... | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of SOCS2 mRNA | CTD | PMID:18687144 |
| cycloheximide | multiple interactions | ISO | RGD:1332166 | 6480464 | Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SOCS2 mRNA] | CTD | PMID:15371557 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SOCS2 mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | decreases expression | ISO | RGD:1332166 | 6480464 | Dibutyl Phthalate results in decreased expression of SOCS2 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1332166 | 6480464 | Dibutyl Phthalate results in decreased expression of SOCS2 mRNA | CTD | PMID:17361019 PMID:21266533 |
| diethylstilbestrol | decreases expression | ISO | RGD:1332166 | 6480464 | Diethylstilbestrol results in decreased expression of SOCS2 mRNA | CTD | PMID:15171707 |
| ethanol | decreases expression | ISO | RGD:1332166 | 6480464 | Ethanol results in decreased expression of SOCS2 mRNA | CTD | PMID:19167417 |
| folic acid | multiple interactions | ISO | RGD:1332166 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SOCS2 gene; more ... | CTD | PMID:20938992 |
| gamma-hexachlorocyclohexane | decreases expression | ISO | RGD:69273 | 6480464 | Lindane results in decreased expression of SOCS2 mRNA | CTD | PMID:17785943 |
| hexachlorobenzene | affects expression | ISO | RGD:69273 | 6480464 | Hexachlorobenzene affects the expression of SOCS2 mRNA | CTD | PMID:15159207 |
| isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of SOCS2 mRNA | CTD | PMID:15982314 |
| L-methionine | multiple interactions | ISO | RGD:1332166 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SOCS2 mRNA; more ... | CTD | PMID:20938992 |
| leflunomide | increases expression | ISO | RGD:1332166 | 6480464 | leflunomide results in increased expression of SOCS2 mRNA | CTD | PMID:19751817 |
| methapyrilene | increases expression | ISO | RGD:69273 | 6480464 | Methapyrilene results in increased expression of SOCS2 mRNA | CTD | PMID:22484513 |
| methylmercury(1+) | increases expression | ISO | RGD:69273 | 6480464 | methylmercury II results in increased expression of SOCS2 mRNA | CTD | PMID:17905399 |
| paracetamol | decreases expression | ISO | RGD:1332166 | 6480464 | Acetaminophen results in decreased expression of SOCS2 mRNA | CTD | PMID:18544908 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SOCS2 mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | ISO | RGD:1332166 | 6480464 | Acetaminophen results in increased expression of SOCS2 mRNA | CTD | PMID:11264010 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:69273 | 6480464 | perfluorooctanoic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:69273 | 6480464 | perfluorooctanoic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:19162173 PMID:21318169 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:69273 | 6480464 | perfluorooctanoic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:21318169 PMID:19162173 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of SOCS2 mRNA | CTD | PMID:19159669 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA | CTD | PMID:16979875 |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:11798191 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:20059764 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | decreases expression | ISO | RGD:1332166 | 6480464 | pirinixic acid results in decreased expression of SOCS2 mRNA | CTD | PMID:17426115 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:1332166 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SOCS2 mRNA] | CTD | PMID:20059764 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:69273 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SOCS2 mRNA | CTD | PMID:19162173 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SOCS2 mRNA | CTD | PMID:19371625 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SOCS2 mRNA | CTD | PMID:19167446 |
| tamoxifen | affects expression | ISO | RGD:1332166 | 6480464 | Tamoxifen affects the expression of SOCS2 mRNA | CTD | PMID:20937368 |
| testosterone | decreases expression | ISO | RGD:1332166 | 6480464 | Testosterone results in decreased expression of SOCS2 mRNA | CTD | PMID:15788153 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of SOCS2 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of SOCS2 mRNA | CTD | PMID:21592394 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SOCS2 mRNA | CTD | PMID:19371625 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of SOCS2 mRNA | CTD | PMID:19167446 |
| tunicamycin | decreases expression | ISO | RGD:1332166 | 6480464 | Tunicamycin results in decreased expression of SOCS2 mRNA | CTD | PMID:17127020 |
| valproic acid | affects expression | ISO | RGD:1332166 | 6480464 | Valproic Acid affects the expression of SOCS2 mRNA | CTD | PMID:17292431 |
| valproic acid | decreases expression | ISO | RGD:69273 | 6480464 | Valproic Acid results in decreased expression of SOCS2 mRNA | CTD | PMID:21318169 |
| valproic acid | decreases expression | ISO | RGD:1332166 | 6480464 | Valproic Acid results in decreased expression of SOCS2 mRNA | CTD | PMID:21427059 |
| vancomycin | decreases expression | ISO | RGD:1332166 | 6480464 | Vancomycin results in decreased expression of SOCS2 mRNA | CTD | PMID:18930951 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA | CTD | PMID:16979875 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of SOCS2 mRNA | CTD | PMID:22171008 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SOCS2 mRNA | CTD | PMID:18593933 |
| zinc sulfate | increases expression | EXP | | 6480464 | Zinc Sulfate results in increased expression of SOCS2 mRNA | CTD | PMID:16330358 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of SOCS2 mRNA | CTD | PMID:16979875 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SOCS2 mRNA | CTD | PMID:18593933 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of SOCS2 mRNA | CTD | PMID:22171008 |